<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02988544</url>
  </required_header>
  <id_info>
    <org_study_id>UF 9751</org_study_id>
    <nct_id>NCT02988544</nct_id>
  </id_info>
  <brief_title>Artificial Shrinkage of Fresh Blastocysts</brief_title>
  <acronym>BlastoCollapse</acronym>
  <official_title>Artificial Shrinkage of Fresh Blastocyst: Impact on Success Rates in Assisted Reproductive Technology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine if collapsing an embryo (or making it fold compactly by
      taking away its fluid) before the transfer in the uterine cavity improves pregnancy rates in
      assisted reproductive technology (ART).

      Women coming to our ART center will be randomized in two groups : the collapsing group and a
      control group.

      Pregnancy rates will be compared in the two groups. A biomarker (cell free DNA) will also be
      determined in each group and correlated to pregnancy occurrence.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective randomized study designed to determine if artificial shrinkage (AS)
      before transfer of embryos impact clinical pregnancy rate in single blastocyst embryo
      transfer (SBET) cycle. Women elected for SBET will be randomized on transfer day in two
      arms:the AS group where blastocoelic cavity is artificially reduced by a laser pulse prior to
      transfer and a control group.

      Clinical pregnancy rates will be compared. Secondarily, rate of monozygotic twin pregnancy
      and cell free DNA concentration in culture medium will be evaluated in the two groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2018</start_date>
  <completion_date type="Anticipated">December 20, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 20, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy rate embryo transfer</measure>
    <time_frame>5 weeks</time_frame>
    <description>Clinical pregnancy rate by transfer evaluate by the visualization of at least one gestational sac with fetal heart activity during pelvic ultrasound confirmed by a positive result of the quantitative Î²HCG blood test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Twin pregnancy rate by transfer</measure>
    <time_frame>5 weeks</time_frame>
    <description>Twin pregnancy rate by transfer evaluate the presence of 2 cardiac activities on ultrasound.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Free DNA level</measure>
    <time_frame>Baseline</time_frame>
    <description>Free DNA content contained in the drop of culture medium collected after transfer.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Infertility Assisted Reproductive Technology</condition>
  <arm_group>
    <arm_group_label>Artificial shrinkage (AS) group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Artificial shrinkage group where blastocoelic cavity is artificially reduced by a laser pulse prior to transfer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention on blastocoelic</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Artificial shrinkage</intervention_name>
    <description>Artificial shrinkage of blastocyst</description>
    <arm_group_label>Artificial shrinkage (AS) group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  eligible patient for transfert of only embryo at the blastocyte step

          -  available patient for a follow up of 12 months

        Exclusion Criteria:

          -  Attempt with frozen embryo or frozen oocyte

          -  Patient has not signed informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>36 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna AG GALA, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna AG GALA, MD</last_name>
    <phone>+334 67 33 64 04</phone>
    <email>a-gala@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Margaux MA ANAV, MD</last_name>
    <phone>+334 67 33 64 04</phone>
    <email>m-anav@chu-montpellier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Montpellier University Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna AG GALA, MD</last_name>
      <phone>+334.67.33.64.04</phone>
      <email>a-gala@chu-montpellier.fr</email>
    </contact>
    <contact_backup>
      <last_name>Margaux MA ANAV, MD</last_name>
      <email>m-anav@chu-montpellier.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Anna GALA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alice FERRIERES-HOA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Margaux ANAV, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 2, 2016</study_first_submitted>
  <study_first_submitted_qc>December 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2016</study_first_posted>
  <last_update_submitted>December 30, 2019</last_update_submitted>
  <last_update_submitted_qc>December 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Single blastocyst embryo transfer</keyword>
  <keyword>Artificial Shrinkage</keyword>
  <keyword>Clinical pregnancy rate</keyword>
  <keyword>Cell free</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

